Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Deferiprone vs Ferriprox in Healthy Volunteers
NCT02980458Phase 1Completed
- Sponsor
- SocraTec R&D
- Start
- Aug 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of deferiprone in iron overload (2 arms), sponsored by SocraTec R&D. Primary endpoints: Area under the plasma concentration versus time curve from time zero to the last measurable concentration at 8 hours and Peak Plasma Concentration at 8 hours. Started Aug 2016; status: completed.
02
Drugs
deferiprone
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT02980458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02980458.